MDT

96.53

+0.95%↑

VEEV

287.9

+0.6%↑

138.07

-0.18%↓

HQY

93.65

+0.53%↑

PHR.US

22.97

+3.56%↑

MDT

96.53

+0.95%↑

VEEV

287.9

+0.6%↑

138.07

-0.18%↓

HQY

93.65

+0.53%↑

PHR.US

22.97

+3.56%↑

MDT

96.53

+0.95%↑

VEEV

287.9

+0.6%↑

138.07

-0.18%↓

HQY

93.65

+0.53%↑

PHR.US

22.97

+3.56%↑

MDT

96.53

+0.95%↑

VEEV

287.9

+0.6%↑

138.07

-0.18%↓

HQY

93.65

+0.53%↑

PHR.US

22.97

+3.56%↑

MDT

96.53

+0.95%↑

VEEV

287.9

+0.6%↑

138.07

-0.18%↓

HQY

93.65

+0.53%↑

PHR.US

22.97

+3.56%↑

Strona główna・Stock List・Essa Pharma Inc

Essa Pharma Inc

Closed

0.19 -5

Buy Sell

Overview

Share price change

24h

Current

Min

0.19

Max

0.19

Key metrics
By Trading Economics
Income	2.4M -4M
Dividend yield	87.56
Employees	35
EBITDA	1.4M -5M

Dividends
By Dow Jones
Dividend yield Sector Avg	87.56% 3.00%

Market Stats
By TradingEconomics
Market Cap	-75M 9.5M
Previous open	5.19
Previous close	0.19

Technical Score

By Trading Central

Confidence

Bearish Evidence

1.7 / 1.72 Support & Resistance

Essa Pharma Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

14 paź 2025, 22:33 UTC

Earnings

America Movil 3Q Profit Jumps on Higher Revenue, Lower Financial Costs

14 paź 2025, 22:21 UTC

Major Market Movers

Dentsply Sirona Shares Rise After SEC Probe Ends

14 paź 2025, 19:27 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20 Billion

14 paź 2025, 17:56 UTC

Major Market Movers

Nova Minerals Surges; Will Provide Minerals Briefing to Australian Government Ahead of Trump Meeting

14 paź 2025, 23:38 UTC

Market Talk

Nikkei May Rise Amid Possible Bargain-Hunting -- Market Talk

14 paź 2025, 22:12 UTC

Market Talk

Earnings

Fletcher Building's 1H Earnings Likely Down 16% -- Market Talk

14 paź 2025, 21:40 UTC

Earnings

America Movil 3Q EBITDA MXN93.82B, Up 4.9% on Year >AMX.MX

14 paź 2025, 21:39 UTC

Earnings

America Movil 3Q Rev MXN232.92B, Up 4.2% on Year >AMX.MX

14 paź 2025, 21:38 UTC

Earnings

America Movil 3Q Net MXN22.7B Vs. Net MXN6.43B Year Ago >AMX.MX

14 paź 2025, 21:06 UTC

Earnings

These Stocks Moved the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

14 paź 2025, 20:50 UTC

Market Talk

Earnings

Financial Services Roundup: Market Talk

14 paź 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 paź 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

14 paź 2025, 20:50 UTC

Market Talk

Earnings

Health Care Roundup: Market Talk

14 paź 2025, 20:13 UTC

Earnings

BlackRock's Assets Hit Record $13.5 Trillion After Market Rally, Dealmaking Spree -- 2nd Update

14 paź 2025, 20:01 UTC

Earnings

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 5th Update

14 paź 2025, 19:21 UTC

Market Talk

Earnings

Citigroup's Higher Outlook Leaves Questions -- Market Talk

14 paź 2025, 19:12 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20B

14 paź 2025, 19:08 UTC

Market Talk

Oil Futures Settle Lower on Trade, Oversupply Concerns -- Market Talk

14 paź 2025, 19:02 UTC

Market Talk

U.S. Natural Gas Falls as Weather Outlook Stays Mild -- Market Talk

14 paź 2025, 18:59 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Bid for Corresponds to Total Enterprise Value of EUR17B for Altice France Assets

14 paź 2025, 18:58 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Bid Excludes Stakes in Intelcia, UltraEdge, XP Fibre, Altice Technical Services

14 paź 2025, 18:58 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Bid Covers Most SFR Assets

14 paź 2025, 18:56 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Submit Joint Non-Binding Offer to Buy Large Part of Altice's Activities in France

14 paź 2025, 18:46 UTC

Earnings

These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

14 paź 2025, 18:04 UTC

Earnings

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 4th Update

14 paź 2025, 18:01 UTC

Market Talk

Gold Finds Another Record as Traders Eye Further Upside -- Market Talk

14 paź 2025, 17:54 UTC

Earnings

Salesforce's Dreamforce Conference Kicks Off. CEO Benioff Touts AI Tool Agentforce. -- Barrons.com

14 paź 2025, 17:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 paź 2025, 17:50 UTC

Market Talk

Lower Dollar Provides Some Strength in Grains -- Market Talk

Peer Comparison

Price change

Essa Pharma Inc Forecast

Rating Consensus

By TipRanks

0 ratings

Buy

Hold

Sell

Based on 0 analysts giving stock ratings to Essa Pharma Inc - Dist in the past 3 months.

Technical Score

By Trading Central

1.7 / 1.72Support & Resistance

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Essa Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.